Chitinase 3 like 1 deficiency ameliorates lipopolysaccharide-induced acute liver injury by inhibition of M2 macrophage polarization
Molecular Immunology · 2023
DOI: 10.1016/j.molimm.2023.02.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Immunology, 2023. Verfasst von Minji Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungb…. Hauptthemen laut MEDLINE: Chitinases, Sepsis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Ministry of Science, ICT and Future Planning, National Research Foundation of Korea.
Abstract (Originalsprache)
Chitinase 3-like-1 protein (CHI3L1) is involved in various infectious diseases, especially sepsis. Aberrant CHI3L1 expression potentially plays a critical role in chronic inflammation because a considerable number of macrophages are associated with immune/inflammatory diseases. In this study, we examined the effect of CHI3L1 on hepatic sepsis injury using a lipopolysaccharide (LPS)-induced model. LPS-treated CHI3L1 knockout (KO) mice exhibited a higher survival rate than LPS-treated CHI3L1 wild-type (WT) mice. In addition, hepatic injury-related enzyme levels (aspartate transaminase, alanine transaminase, and lactate dehydrogenase) decreased in CHI3L1 KO mice sera, suggesting attenuated LPS-induced septic liver damage in CHI3L1 KO mice. A greater reduction in the mRNA and protein expressions of M2 polarization markers, such as MRC1, ARG1, IL-10, and IL-4, was observed in LPS-induced CHI3L1 KO mice livers than in LPS-induced WT mice livers. Nonetheless, no change in the mRNA and protein expressions of M1 polarization markers, such as INOS, CD86, TNF-α, and IL6, was noted in LPS-induced CHI3L1 KO mice livers compared with those in LPS-induced WT and KO mice. Similar to the in vivo scenario, liver CHI3L1 depletion in LPS-treated HEP3B cells significantly decreased M2 polarization marker protein expression. However, M1 polarization marker protein expression did not differ significantly. These results suggest that CHI3L1 depletion decreases M2 macrophage polarization, and this effect is potentially associated with the alleviation of liver sepsis in CHI3L1 KO mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 361-951, Republic of Korea.
- College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
- Department of Biological Sciences, College of Natural Sciences, Chonnam National University, Gwangju 61186, Republic of Korea.
- College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 361-951, Republic of Korea. Electronic address: jinthong@chungbuk.a…
Förderung
- Ministry of Science, ICT and Future Planning
- National Research Foundation of Korea
Zitieren
APA
Kim, M., Chang, J. Y., Lee, D. W., Kim, Y. R., Son, D. J., Yun, J., Jung, Y. S., Lee, D. H., Han, S., & Hong, J. T. (2023). Chitinase 3 like 1 deficiency ameliorates lipopolysaccharide-induced acute liver injury by inhibition of M2 macrophage polarization. Molecular Immunology. https://doi.org/10.1016/j.molimm.2023.02.012
Vancouver
Kim M, Chang JY, Lee DW, Kim YR, Son DJ, Yun J, et al. Chitinase 3 like 1 deficiency ameliorates lipopolysaccharide-induced acute liver injury by inhibition of M2 macrophage polarization. Molecular Immunology. 2023. doi:10.1016/j.molimm.2023.02.012
BibTeX
@article{Kim2023,
author = {Kim, Minji and Chang, Ju Young and Lee, Dong Won and Kim, Yu Ri and Son, Dong Ju and Yun, Jaesuk and Jung, Young Suk and Lee, Dong Hun and Han, Sangbae and Hong, Jin Tae},
title = {Chitinase 3 like 1 deficiency ameliorates lipopolysaccharide-induced acute liver injury by inhibition of M2 macrophage polarization},
journal = {Molecular Immunology},
year = {2023},
doi = {10.1016/j.molimm.2023.02.012}
}
EUVIMED